 |
| click to enlarge |
FROM THE ISDS EVENT: (source: isds2023.org/program/)
The “5th Inflammatory Skin Disease Summit: The Translational Revolution” (is) a unique and dynamic symposium, being held in Vienna, Austria, at the “Aula der Wissenschaften” on November 15-18, 2023. After four very successful meetings in Vienna and in New York City in 2014, 2016, 2018 and 2021, we have again taken upon the task of organizing such an important in-person meeting, in order to continue this path of therapeutic revolution and extend to other inflammatory skin diseases. We want to discuss new concepts and new developments in the field of inflammatory skin diseases and to devise and explore new therapeutic strategies. For the last meetings, we had been able to attract true leaders in their fields, with more than 600 participants from all over the world at the last meetings in New York (2021) and Vienna (2018). We have now established this conference on an every two-year basis."
According to a project manager from Mondial Congress & Events, "we are the biggest Professional Congress Organizer in Austria (PCO)... We have been working for ISDS and supported the organizing committee with the organization/logistics since the first edition in 2014. The community of ISDS is growing each year and. This year we are excited to welcome the community to our hometown." She added that this ISDS event had "more than 600 people registered, 33 Oral abstract presentations and 44 faculty speakers and a poster exhibition of over 279 abstracts have been accepted this year"
A LEGACY OF RESEARCH & EDUCATION
Since the inception of his profound career in cancer research and advanced diagnostic imaging (1974), Dr. Bard has been a staunch supporter of non‐invasive imaging technologies that has proven to offer significant quantitative biometrics for a wide range of clinical uses. He has authored an expansive list of medical texts and articles in medical journals about cancer imaging and reports about technological innovations. Moreover, he remains active throughout his unending career by having presented in over 200 medical summits, symposiums and conferences both domestic and in Europe. From pre and post‐op scanning, clinical research validation and 2nd opinion scans, Dr. Bard's mission as a medical educator is to mobilize more effective strategies in pathology reporting and data gathering through the use of ultrasound functions. He is globally recognized in conferences and throughout the medical media for his informative presentations and published textbooks on diagnostic imaging science‐ including his highly referenced IMAGE GUIDED PROCEDURES series.
Dr. Bard employs the use of 3D Doppler Sonogram and elastography imaging to collect biometric data and to record the efficacy of therapeutic solutions. This includes an array of information including the quantifiable measurement of blood flow, muscle contractions and the temporal measurement of the treatment’s effects on inflammation. For this specific presentation, the technology called PEMF (Pulsed Electromagnetic Field) technologist Patrick Ziemer, founder of Aurawell PEMF to support this dermatological study by donating various product models to Dr. Bard’s research center. “We recognize the value of Dr. Bard’s findings for the continuance and advancement of PEMF research… and certainly proving (clinically) that PEMF can affect the outcome and care of inflammatory skin disorders through imaging is a medical milestone for the non‐invasive and alternative health movements.”
PATRICK ZIEMER: CRUSADER IN NON‐INVASIVE THERAPY MOVEMENT
AURA Wellness PEMF is a major sponsor of Dr. Bard’s latest presentation and a contributor to PEMF innovations for his research. Mr Ziemer himself is part of the ISDS Vienna Conference exhibitor lineup on November 15‐18. With an extensive history in the development of PEMF science, Pat Ziemer started in 2002, co‐developing and promoting the therapeutic use of PEMF in the equine society and expanded to high‐power applications in 2007.
His PEMF devices have shown to improve horses’ circulation, increasing blood oxygen, lymphatic stimulation, relaxing muscle spasms, enhancing muscle tone, and increasing the range of motion in high performance horses. In 2020, Mr. Ziemer’s PEMF officially made its way to human patients at the launch of AURA Wellness (brand)‐ carrying a professional grade, high voltage PEMF model while helping advance tremendous research and development toward the application of for‐human prototypes.
RESEARCH & VALIDATION
It is noted that Dr. Bard continues to conduct pilot studies and publishing efficacy studies with PEMF devices (and other non‐invasive modalities)‐ including the latest models donated by AURA WELLNESS. Dr. Bard’s research and publishing programs include exploratory testing for Pulsed Bioenergy solutions for enlarged prostate (hyperplasia), dense breast tissue, endometrial symptoms, inflammatory skin disorders, urinary incontinence and an array of other health issues. His work is under AngioResearch (501c3) and the recently launched Integrative Health Research Center in NYC.
